In situ formation of chitosan-cyclodextrin nanospheres for drug delivery

Colloids and Surfaces B: Biointerfaces

Volumn 87, Issue 1, 2011, Pages 198-202

  Wang, Jun ^a   Zong, Jing Yi ^a   Zhao, Dong ^a   Zhuo, Ren Xi ^a   Cheng, Si Xue ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Controlled drug release; Cyclodextrin; Nanospheres; Polysaccharides

Indexed keywords

ANTICANCER DRUG; AQUEOUS MEDIUM; CONTROLLED DRUG RELEASE; DOXORUBICIN HYDROCHLORIDE; ENCAPSULATION EFFICIENCY; FACILE PREPARATION; HELA CELL; IN-SITU FORMATIONS; IN-VITRO; MICHAEL ADDITIONS; NARROW SIZE DISTRIBUTIONS; PARTICLE SIZE ANALYZERS; PREPARATION CONDITIONS; SODIUM SALT; WATERSOLUBLE;

ADDITION REACTIONS; CHITOSAN; CONTROLLED DRUG DELIVERY; ENCAPSULATION; ORGANIC SOLVENTS; PARTICLE SIZE ANALYSIS; SURFACE ACTIVE AGENTS;

NANOSPHERES;

BETA CYCLODEXTRIN; CHITOSAN; DOXORUBICIN; NANOSPHERE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG MIXTURE; DRUG STABILITY; DRUG SYNTHESIS; HELA CELL; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; MOLECULAR WEIGHT; NANOENCAPSULATION; PARTICLE SIZE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

CELL DEATH; CHITOSAN; CYCLODEXTRINS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; HELA CELLS; HUMANS; NANOSPHERES; PARTICLE SIZE;

EID: 79959332916     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2011.05.020     Document Type: Article

References (17)

1. Kim S., Kim J.H., Jeon O., Kwon I.C., Park K. Eur. J. Pharm. Biopharm. 2009, 71:420.
2. Talelli M., Rijcken C.J.F., van Nostrum C.F., Storm G., Hennink W.E. Adv. Drug Deliv. Rev. 2010, 62:231.
3. des Rieux A., Fievez V., Garinot M., Schneider Y.J., Préat V. J. Control. Release 2006, 116:1.
4. Lees-Haley P.R., Williams C.W. J. Clin. Psychol. 1997, 53:699.
5. Patel M.P., Patel R.R., Patel J.K. J. Pharm. Pharm. Sci. 2010, 13:536.
6. Aranaz I., Harris R., Heras A. Curr. Org. Chem. 2010, 14:308.
7. Bodnar M., Hartmann J.F., Borbely J. Biomacromolecules 2005, 6:2521.
8. Li J., Loh X.J. Adv. Drug Deliv. Rev. 2008, 60:1000.
9. Oda Y., Miura M., Hattori K., Yamanoi T. Chem. Pharm. Bull. 2009, 57:74.
10. Prabaharan M., Mano J.F. Macromol. Biosci. 2005, 5:965.
11. Lu B., Xu X.D., Zhang X.Z., Cheng S.X., Zhuo R.X. Biomacromolecules 2008, 9:2594.
12. Peng K., Tomatsu I., Korobko A.V., Kros A. Soft Matter 2010, 6:85.
13. Chen W., Meng F., Cheng R., Zhong Z. J. Control. Release 2010, 142:40.
14. Shen Y., Jin E., Zhang B., Murphy C.J., Sui M., Zhao J., Wang J., Tang J., Fan M., Kirk E.V., Murdoch W.J. J. Am. Chem. Soc. 2010, 132:4259.
15. Momparber R.L., Karon M., Siegel S.E., Avila F. Cancer Res. 1976, 36:2891.
16. Czeczuga-Semeniuk E., Wołczyński S., Daogonekbrowska M., Dzieogonekcioł J., Anchim T. Folia Histochem. Cyto. 2004, 42:221.
17. Rossi M., Munarriz E.R., Bartesaghi S., Milanese M., Dinsdale D., Guerra-Martin M.A., Bampton E.T.W., Glynn P., Bonanno G., Knight R.Am., Nicotera P., Melino G. J. Cell Sci. 2009, 122:3330.